Antimicrobial peptide having synergistic antibacterial effect with antibiotics on multidrug resistant bacteria, and use thereof
View Patent ↗The present invention relates to an antimicrobial peptide having an improved antibacterial effect through glutamic acid substitution and, more specifically, to a use of the antimicrobial peptide as an active ingredient in an antibacterial pharmaceutical composition, a food additive, a feed additive, an antiseptic composition, and an antibacterial quasi-drug composition. Not only does the antimicrobial peptide of the present invention exhibit significant antibacterial activity against gram-negative bacteria, but it also exhibits a significant synergistic effect when combinedly treated with antibiotics which have strong antibacterial activity only against gram-positive bacteria and has no or low antibacterial activity against gram-negative bacteria, thereby exhibiting excellent antibacterial effects on gram-positive bacteria, E. coli and Acinetobacter bacteria among gram-negative bacteria, and antibiotic-resistant strains thereof.
1. An antimicrobial peptide consisting of the amino acid sequence obtained by modifying the amino acid sequence of SEQ ID No. 1, wherein the amino acid sequence of SEQ ID No. 1 is modified with one or more substitutions selected from the group consisting of the following (i) to (v):
(i) substitution of proline (P) which is the 9th amino acid with D-lysine (k) or D-leucine (1), and substitution of phenylalanine (F) which is the 11th amino acid with leucine (L);
(ii) substitution of phenylalanine (F) which is the 11th amino acid with leucine (L);
(iii) substitution of serine (S) which is the 14th amino acid with glutamic acid (E) or L-lysine (K);
(iv) substitution of alanine (A) which is the 15th amino acid with tryptophan (W), phenylalanine (F), or leucine (L); and
(v) substitution of phenylalanine (F) which is the 18th amino acid with tryptophan (W).
2. The antimicrobial peptide of claim 1 , wherein the antimicrobial peptide consists of any one amino acid sequence selected from the group consisting of SEQ ID Nos. 2 to 24.
3. An antimicrobial composition comprising the antimicrobial peptide of claim 1 as an active ingredient.
4. The antimicrobial composition of claim 3 further comprising antibiotics as active ingredients.
5. The antimicrobial composition of claim 3 , wherein the antimicrobial peptide consists of any one amino acid sequence selected from the group consisting of SEQ ID Nos. 2 to 24.
6. The antimicrobial composition of claim 3 , wherein the antimicrobial composition has antibacterial activity against gram-positive bacteria, gram-negative bacteria, and antibiotic-resistant strains thereof.
7. The antimicrobial composition of claim 6 , wherein the gram-positive bacteria are one or more selected from the group consisting of Bacillus subtilis, Staphylococcus aureus and Staphylococcus epidermis , and wherein the gram-negative bacteria are one or more selected from the group consisting of Escherichia coli, Pseudomonas aeruginosa, Acinetobacter baumannii and Salmonella typhimurium.
8. The antimicrobial composition of claim 4 , wherein the antibiotics are one or more selected from the group consisting of erythromycin, ampicillin, vancomycin, linezolid, methicillin, oxacillin, cefotaxime, rifampicin, amikacin, gentamicin, amikacin, kanamycin, tobramycin, neomycin, ertapenem, doripenem, imipenem/cilastatin, meropenem, ceftazidime, cefepime, ceftaroline, ceftobiprole, aztreonam, piperacillin, polymyxin b, colistin, ciprofloxacin, levofloxacin, moxifloxacin, gatifloxacin, tigecycline, a conjugate thereof, and derivatives thereof.
9. The antimicrobial composition of claim 3 , wherein the antimicrobial composition is any one selected from the group consisting of a pharmaceutical composition, a food additive, a feed additive, an antiseptic composition, and a quasi-drug composition.
10. The antimicrobial peptide of claim 1 , wherein the antimicrobial peptide is administered in combination with an antibiotic.
11. The antimicrobial peptide of claim 10 , wherein the antibiotic is at least one or more of erythromycin, ampicillin, vancomycin, linezolid, methicillin, oxacillin, cefotaxime, rifampicin, amikacin, gentamicin, amikacin, kanamycin, tobramycin, neomycin, ertapenem, doripenem, imipenem/cilastatin, meropenem, ceftazidime, cefepime, ceftaroline, ceftobiprole, aztreonam, piperacillin, polymyxin b, colistin, ciprofloxacin, levofloxacin, moxifloxacin, gatifloxacin, tigecycline, or a conjugate thereof, or a derivative thereof.
12. The antimicrobial peptide of claim 10 , wherein the antimicrobial peptide in combination with the antibiotic has antibacterial activity against gram-positive bacteria, gram-negative bacteria, and antibiotic-resistant strains thereof.
13. The antimicrobial peptide of claim 12 , wherein the gram-positive bacteria is at least one or more of Bacillus subtilis, Staphylococcus aureus , or Staphylococcus epidermidis , and wherein the gram-negative bacteria is at least one or more of Escherichia coli, Pseudomonas aeruginosa, Acinetobacter baumannii , or Salmonella typhimurium.